1. Home
  2. CTRI vs DYN Comparison

CTRI vs DYN Comparison

Compare CTRI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$29.93

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$19.32

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRI
DYN
Founded
1909
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
CTRI
DYN
Price
$29.93
$19.32
Analyst Decision
Hold
Strong Buy
Analyst Count
5
14
Target Price
$29.88
$37.00
AVG Volume (30 Days)
1.0M
1.6M
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
N/A
EPS
N/A
N/A
Revenue
$2,982,781,000.00
N/A
Revenue This Year
$14.62
N/A
Revenue Next Year
$8.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.10
N/A
52 Week Low
$19.04
$8.25
52 Week High
$42.99
$25.00

Technical Indicators

Market Signals
Indicator
CTRI
DYN
Relative Strength Index (RSI) 44.77 58.02
Support Level $27.81 $16.47
Resistance Level $31.98 $19.54
Average True Range (ATR) 1.29 1.18
MACD 0.14 0.17
Stochastic Oscillator 41.35 71.08

Price Performance

Historical Comparison
CTRI
DYN

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: